[HTML][HTML] Trends in Drug Costs and Overall Survival in Patients with Metastatic Non-small Cell Lung Cancer in The Netherlands Diagnosed from 2008 Through 2014
CM Cramer-van der Welle, BJM Peters… - PharmacoEconomics …, 2021 - Springer
Abstract Background The Value-Based Health Care concept defines patient value as patient-
relevant outcomes divided by costs. The aim of the present study was to assess the …
relevant outcomes divided by costs. The aim of the present study was to assess the …
[HTML][HTML] Trends in Drug Costs and Overall Survival in Patients with Metastatic Non-small Cell Lung Cancer in The Netherlands Diagnosed from 2008 Through 2014
CM Cramer-van der Welle, BJM Peters… - PharmacoEconomics …, 2021 - ncbi.nlm.nih.gov
Background The Value-Based Health Care concept defines patient value as patient-relevant
outcomes divided by costs. The aim of the present study was to assess the development of …
outcomes divided by costs. The aim of the present study was to assess the development of …
Trends in Drug Costs and Overall Survival in Patients with Metastatic Non-small Cell Lung Cancer in The Netherlands Diagnosed from 2008 Through 2014
CMC van der Welle, BJM Peters… - …, 2021 - econpapers.repec.org
Abstract Background The Value-Based Health Care concept defines patient value as patient-
relevant outcomes divided by costs. The aim of the present study was to assess the …
relevant outcomes divided by costs. The aim of the present study was to assess the …
Trends in Drug Costs and Overall Survival in Patients with Metastatic Non-small Cell Lung Cancer in The Netherlands Diagnosed from 2008 Through 2014
CM Cramer-van der Welle, BJM Peters… - …, 2021 - search.proquest.com
Background The Value-Based Health Care concept defines patient value as patient-relevant
outcomes divided by costs. The aim of the present study was to assess the development of …
outcomes divided by costs. The aim of the present study was to assess the development of …
Trends in Drug Costs and Overall Survival in Patients with Metastatic Non-small Cell Lung Cancer in The Netherlands Diagnosed from 2008 Through 2014
CM Cramer-van der Welle, BJM Peters… - PharmacoEconomics …, 2021 - ideas.repec.org
Background The Value-Based Health Care concept defines patient value as patient-relevant
outcomes divided by costs. The aim of the present study was to assess the development of …
outcomes divided by costs. The aim of the present study was to assess the development of …
[PDF][PDF] Trends in Drug Costs and Overall Survival in Patients with Metastatic Non‑small Cell Lung Cancer in The Netherlands Diagnosed from 2008 Through 2014
CM Cramer‑van der Welle, BJM Peters, MJ Deenen… - 2020 - scholar.archive.org
Abstract Background The Value-Based Health Care concept defines patient value as patient-
relevant outcomes divided by costs. The aim of the present study was to assess the …
relevant outcomes divided by costs. The aim of the present study was to assess the …
Trends in Drug Costs and Overall Survival in Patients with Metastatic Non-small Cell Lung Cancer in The Netherlands Diagnosed from 2008 Through 2014
CM Cramer-van der Welle… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Background The Value-Based Health Care concept defines patient value as patient-relevant
outcomes divided by costs. The aim of the present study was to assess the development of …
outcomes divided by costs. The aim of the present study was to assess the development of …
[PDF][PDF] Trends in Drug Costs and Overall Survival in Patients with Metastatic Non‑small Cell Lung Cancer in The Netherlands Diagnosed from 2008 Through 2014
CM Cramer‑van der Welle, BJM Peters, MJ Deenen… - 2020 - researchgate.net
Abstract Background The Value-Based Health Care concept defines patient value as patient-
relevant outcomes divided by costs. The aim of the present study was to assess the …
relevant outcomes divided by costs. The aim of the present study was to assess the …
Trends in Drug Costs and Overall Survival in Patients with Metastatic Non-small Cell Lung Cancer in The Netherlands Diagnosed from 2008 Through 2014.
CM Cramer-van der Welle, BJM Peters… - Pharmacoeconomics …, 2021 - europepmc.org
Background The Value-Based Health Care concept defines patient value as patient-relevant
outcomes divided by costs. The aim of the present study was to assess the development of …
outcomes divided by costs. The aim of the present study was to assess the development of …
[PDF][PDF] Trends in Drug Costs and Overall Survival in Patients with Metastatic Non‑small Cell Lung Cancer in The Netherlands Diagnosed from 2008 Through 2014
CM Cramer‑van der Welle, BJM Peters, MJ Deenen… - 2020 - d-nb.info
Abstract Background The Value-Based Health Care concept defines patient value as patient-
relevant outcomes divided by costs. The aim of the present study was to assess the …
relevant outcomes divided by costs. The aim of the present study was to assess the …